Abstract
As a highly specialized shock-absorbing connective tissue, articular cartilage (AC) has very limited self-repair capacity after traumatic injuries, posing a heavy socioeconomic burden. Common clinical therapies for small- to medium-size focal AC defects are well-developed endogenous repair and cell-based strategies, including microfracture, mosaicplasty, autologous chondrocyte implantation (ACI), and matrix-induced ACI (MACI). However, these treatments frequently result in mechanically inferior fibrocartilage, low cost-effectiveness, donor site morbidity, and short-term durability. It prompts an urgent need for innovative approaches to pattern a pro-regenerative microenvironment and yield hyaline-like cartilage with similar biomechanical and biochemical properties as healthy native AC. Acellular regenerative biomaterials can create a favorable local environment for AC repair without causing relevant regulatory and scientific concerns from cell-based treatments. A deeper understanding of the mechanism of endogenous cartilage healing is furthering the (bio)design and application of these scaffolds. Currently, the utilization of regenerative biomaterials to magnify the repairing effect of joint-resident endogenous stem/progenitor cells (ESPCs) presents an evolving improvement for cartilage repair. This review starts by briefly summarizing the current understanding of endogenous AC repair and the vital roles of ESPCs and chemoattractants for cartilage regeneration. Then several intrinsic hurdles for regenerative biomaterials-based AC repair are discussed. The recent advances in novel (bio)design and application regarding regenerative biomaterials with favorable biochemical cues to provide an instructive extracellular microenvironment and to guide the ESPCs (e.g. adhesion, migration, proliferation, differentiation, matrix production, and remodeling) for cartilage repair are summarized. Finally, this review outlines the future directions of engineering the next-generation regenerative biomaterials toward ultimate clinical translation.
Original language | English |
---|---|
Pages (from-to) | 490-512 |
Number of pages | 23 |
Journal | Bioactive Materials |
Volume | 26 |
DOIs | |
Publication status | Published - Aug 2023 |
Bibliographical note
Funding Information:This work was supported by the Areas of Excellence Scheme from University Grant Council of Hong Kong (AoE/M-402/20), the AO Foundation, Switzerland (AO-OCD Consortium TA1711481), the Theme-based Research Scheme from University Grant Council of Hong Kong (T13-402/17-N) as well as the Mainland-Hong Kong Joint Funding Scheme of Innovation and Technology Fund: ITF MHKJFS (MHP/011/20). Besides, thank Dr. Kevin Ki-Wai Ho and Dr. Yang Liu for providing valuable clinical theranostics photographs of human knee cartilage defects.
Publisher Copyright:
© 2023 The Authors